Position in GILD
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$1,054,559
+$66,008 QoQ
Shares Held
8,347
+17.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1,046
of 2,265 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026IFP Advisors, Inc holds $69,954,680 across 17 Drug Manufacturers - General names. GILD ranks #11 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
20,352 | $24,410,801 | |
| 2 | ABBV |
AbbVie Inc.
|
52,930 | $13,319,305 | |
| 3 | JNJ |
Johnson & Johnson
|
38,760 | $9,843,877 | |
| 4 | PFE |
Pfizer Inc
|
228,411 | $5,500,136 | |
| 5 | MRK |
Merck & Co., Inc.
|
30,895 | $3,970,007 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
57,120 | $3,291,254 | |
| 7 | AMGN |
Amgen Inc
|
8,216 | $2,975,177 | |
| 8 | NVO |
Novo Nordisk A S
|
30,253 | $1,450,328 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,054,559 | 8,347 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $988,551 | 7,093 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $1,244,460 | 10,139 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,221,333 | 11,003 | Shares | Sole | 2026-02-06 | |
| 2025-06-30 | $747,818 | 6,745 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $1,470,208 | 13,121 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $1,231,292 | 13,330 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $453,658 | 5,411 | Shares | Sole | 2025-02-04 | |
| 2024-06-30 | $492,825 | 7,183 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $749,494 | 10,232 | Shares | Sole | 2024-07-30 | |
| 2023-12-31 | $770,324 | 9,509 | Shares | Sole | 2024-01-09 | |
| 2023-09-30 | $665,092 | 8,875 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $861,642 | 11,180 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $1,061,767 | 12,797 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $4,151,190 | 48,354 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $3,304,239 | 53,562 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $15,514 | 251 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,381,974 | 23,246 | Shares | Sole | 2022-08-08 | |
| 2021-12-31 | $1,812,272 | 24,959 | Shares | Sole | 2022-01-12 | |
| 2021-09-30 | $645,693 | 9,244 | Shares | Sole | 2021-10-06 | |
| 2021-06-30 | $609,686 | 8,854 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $424,295 | 6,565 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $605,263 | 10,389 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $701,029 | 11,094 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $918,586 | 11,939 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $742,665 | 9,934 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||